Faculty of Pharmaceutical Sciences

Activities

Activities per year 1990 2011 2012 2013 2014 2015 2016 2017 2018 2025

• 2140 Oral presentation
• 78 social activities
• 52 Academic activities
• 18 Invited talk
• 12 More
  • 5 Other reseach activity
  • 5 Other educational activity
  • 1 Participating in a conference, workshop
  • 1 Editorial work

Activities per year

Search results

• 視床下部オレキシンによる臓器連関を介した二相性の肝糖産生の調節作用

  Tsuneki, H. (Speaker)

  2011/03/22 → 2011/03/24

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンによる臓器連関を介した二相性の肝糖産生の調節作用

  Sasaoka, T. (Speaker)

  2011/03/22 → 2011/03/24

  Activity: Talk or presentation › Oral presentation

• 薬物依存関連分子shati遺伝子欠損マウスにおける行動異常と脳内の生化学的な変化

  Nitta, A. (Speaker)

  2011/03/22 → 2011/03/24

  Activity: Talk or presentation › Oral presentation

• タイプII型ピレスロイド殺虫剤によって誘導されるBDNF遺伝子発現制御系に関する解析

  Ihara, D. (Speaker)

  2011/03

  Activity: Talk or presentation › Oral presentation

• 《紹介・書評》浅見洋編『鈴木大拙と日本文化』

  Miyajima, M. (Participant)

  2011/03

  Activity: Other › Other reseach activity

• Pre-administration of docetaxel inhibits Adriamycin-induced cardiotoxicity

  To, H. (Speaker)

  2011/03

  Activity: Talk or presentation › Oral presentation

• 精神病関連遺伝子及びドパミン受容体脳部位特異発現の覚醒剤応答性への影響

  Nitta, A. (Speaker)

  2011/02/28

  Activity: Talk or presentation › Oral presentation

• 加齢に伴うインスリン抵抗性の分子メカニズム

  Sasaoka, T. (Speaker)

  2011/02/18 → 2011/02/19

  Activity: Talk or presentation › Oral presentation

• 悪性腫瘍性疼痛モデルにおける脊髄興奮性入力の可塑的変化

  Uta, D. (Speaker)

  2011/02/05

  Activity: Talk or presentation › Oral presentation

• TRPA1受容体活性化によるラット脊髄後角膠様質細胞に対するシナプス伝達の作用解析

  Uta, D. (Speaker)

  2011/02/05

  Activity: Talk or presentation › Oral presentation

• 覚せい剤精神病関連遺伝子Shatiの脳部位特異的発現がマウス行動に及ぼす影響

  Nitta, A. (Speaker)

  2011/02/04

  Activity: Talk or presentation › Oral presentation

• 薬物依存関連分子Shatiの新規機能解析

  Nitta, A. (Speaker)

  2011/02/04

  Activity: Talk or presentation › Oral presentation

• 悪性腫瘍性疼痛モデルにおける脊髄興奮性入力の可塑的変化.

  Uta, D. (Speaker)

  2011/02

  Activity: Talk or presentation › Oral presentation

• Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Wada, T. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• Overexpression of SHIP2 causes hypothalamic insulin but not leptin resistance in the regulation of glucose homeostasis in mice.

  Wada, T. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• Overexpression of SHIP2 causes hypothalamic insulin but not leptin resistance in the regulation of glucose homeostasis in mice.

  Tsuneki, H. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Sasaoka, T. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• Overexpression of SHIP2 causes hypothalamic insulin but not leptin resistance in the regulation of glucose homeostasis in mice.

  Sasaoka, T. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Tsuneki, H. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• S25. Gene regulation and sonotransfection by low-intensity ultrasound resulting in malignant melanoma inhibition(Oral Presentation)

  Tabuchi, Y. (Speaker)

  2011

  Activity: Talk or presentation › Oral presentation

• TGF-beta activated kinase 1 (TAK1) は放射線照射下のHeLa細胞において細胞周期停止と細胞生存を促進する

  Tabuchi, Y. (Speaker)

  2011

  Activity: Talk or presentation › Oral presentation

• 1,4-Brook 転位を経由したシリルジエノールエーテルの新規合成法の開発

  Matsuya, Y. (Speaker)

  2011

  Activity: Talk or presentation › Oral presentation

• 植物ポリケタイド合成酵素を利用した分子多様性の創出

  Morita, H. (Speaker)

  2012/12/22

  Activity: Talk or presentation › Oral presentation

• Engineering of plant type III polyketide synthase

  Morita, H. (Speaker)

  2012/12/15

  Activity: Talk or presentation › Oral presentation

• 局所麻酔薬レボブピバカインのrNav1.8 チャネルに対する作用

  Uta, D. (Speaker)

  2012/12/13 → 2012/12/14

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンの糖代謝リズム制御による2型糖尿病マウスの高血糖改善効果

  Sasaoka, T. (Speaker)

  2012/12/08

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンの糖代謝リズム制御による2型糖尿病マウスの高血糖改善効果

  Wada, T. (Speaker)

  2012/12/08

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンの糖代謝リズム制御による2型糖尿病マウスの高血糖改善効果

  Tsuneki, H. (Speaker)

  2012/12/08

  Activity: Talk or presentation › Oral presentation

• Introduction of NAIST, and Our Recent Progress of New Synthetic methods Using Nitrogen Functional Groups

  Tanimoto, H. (Speaker)

  2012/12/06

  Activity: Talk or presentation › Oral presentation

• IL-17-producing NK1.1–CD27–γδT cells promote tumor malignant progression by inducing inflammatory microenvironment

  Hayakawa, Y. (Speaker)

  2012/12/05 → 2012/12/07

  Activity: Talk or presentation › Oral presentation

• 局所麻酔薬レボブピバカインのrNav1.8 チャネルに対する作用.

  Uta, D. (Speaker)

  2012/12

  Activity: Talk or presentation › Oral presentation

• 特別研究員等審査会専門委員及び国際事業委員会書面審査員

  Nitta, A. (Participant)

  2012/12 → 2015/03

  Activity: Other › social activities

• 薬事研究会主催 薬事講演会講師

  Nitta, A. (Participant)

  2012/12

  Activity: Other › social activities

• 科学研究費委員会専門委員（基礎研究等

  Nitta, A. (Participant)

  2012/12 → 2016/10

  Activity: Other › social activities

• 科学研究費委員会　専門委員

  Nitta, A. (Participant)

  2012/12 → 2013/11

  Activity: Other › social activities

• 平成２４年度「薬物乱用防止教室」講習会　富山県教育委員会スポーツ・保健課

  Nitta, A. (Participant)

  2012/12

  Activity: Other › social activities

• 二次代謝酵素のX線結晶構造解析と非天然型化合物群の創出

  Morita, H. (Speaker)

  2012/11/27

  Activity: Talk or presentation › Oral presentation

• Development of Electrophilic Amination with α-Oxime-esters

  Tanimoto, H. (Speaker)

  2012/11/20

  Activity: Talk or presentation › Oral presentation

• 光ヒドロキシ基を有するアシルスルホンアミド型光アフィニティープローブの開発

  Tomohiro, T. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 脳インスリン抵抗性に伴う脳高次機能障害に対するリピッドホスファターゼSHIP2阻害剤の改善効果の解析

  Wada, T. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 5’-リピッドホスファターゼSHIP2が摂食行動に与える影響の解析と, SHIP2を標的とした新規耐糖能改善薬の開発

  Wada, T. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 光反応性脂肪酸プローブによる脂肪酸結合タンパク質のラベル化

  Tomohiro, T. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 脳インスリン抵抗性に伴う脳高次機能障害に対するリピッドホスファターゼSHIP2阻害剤の改善効果の解析

  Sasaoka, T. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 脳インスリン抵抗性に伴う脳高次機能障害に対するリピッドホスファターゼSHIP2阻害剤の改善効果の解析

  Tsuneki, H. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 5’-リピッドホスファターゼSHIP2が摂食行動に与える影響の解析と, SHIP2を標的とした新規耐糖能改善薬の開発

  Tsuneki, H. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• タンパク質機能部位の質量差解析を目的とした桂皮酸型光クロスリンカーの開発

  Tomohiro, T. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• ヒドロキシ基を有するアシルスルホンアミド型光アフィニティープローブの開発

  Chiba, J. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 5’-リピッドホスファターゼSHIP2が摂食行動に与える影響の解析と, SHIP2を標的とした新規耐糖能改善薬の開発

  Sasaoka, T. (Speaker)

  2012/11/18

  Activity: Talk or presentation › Oral presentation

• 痒み物質の皮膚塗布により誘起される行動学的解析とin vivoパッチクランプ記録法を用いた脊髄後角におけるシナプス応答の解析

  Uta, D. (Speaker)

  2012/11/16 → 2012/11/17

  Activity: Talk or presentation › Oral presentation

• Inhibition of meneralocorticoid receptor ameliorates insulin resistance and metabolic syndrome in mice.

  Sasaoka, T. (Speaker)

  2012/11/15 → 2012/11/17

  Activity: Talk or presentation › Oral presentation